Table 2 Comparison of cases with chronic... | American Society of Hematology

Table 2

Comparison of cases with chronic HIV-infected patients

Measurements	Cases (n = 4)	LTNPs/ECs (n = 43)	Progressors (n = 18)	Rx<50 (n = 53)
Median duration of HIV diagnosis, y (range)	9 (1-14)	20 (5-32)*	18 (2-25)	17 (6-27)*
Median CD4⁺ T-cell count, cells/mm³ (range)	921 (650-1488)	851 (277-1813)	343 (142-1040)*	587 (204-1409)*
Median HIV-1 RNA levels, copies/mL (range)	< 50	< 50	62 233 (10 443-160 954)*	< 50
Median single-copy assay, copies/mL (range)†	< 1	4 (< 1-48)	NA	< 1 (< 1-53)
Prevalence HLA B*57, %‡	50	63	28	19

Measurements	Cases (n = 4)	LTNPs/ECs (n = 43)	Progressors (n = 18)	Rx<50 (n = 53)
Median duration of HIV diagnosis, y (range)	9 (1-14)	20 (5-32)*	18 (2-25)	17 (6-27)*
Median CD4⁺ T-cell count, cells/mm³ (range)	921 (650-1488)	851 (277-1813)	343 (142-1040)*	587 (204-1409)*
Median HIV-1 RNA levels, copies/mL (range)	< 50	< 50	62 233 (10 443-160 954)*	< 50
Median single-copy assay, copies/mL (range)†	< 1	4 (< 1-48)	NA	< 1 (< 1-53)
Prevalence HLA B*57, %‡	50	63	28	19

NA indicates not available.

P < .05, cases versus other patient groups.

Results from 26 LTNPs/ECs and 51 Rx<50 were used in comparison with the cases.

Sample size was too small to determine a significant difference between group frequencies.